ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

12 links0 made here, not in the record12 judgments1 judge (the rules as one: Rule based)0 record changes seen
Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06378866Stereotactic Body RadiationTherapy Plus Immediate orDelayed Androgen ReceptorPathway Inhibitor andAndrogen DeprivationTherapy or SalvageRadiation Therapy for theMayo ClinicPhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSProstatic NeoplasmsThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSAbirateroneIntervention entry›As of now · Rule based · ComparatorComparatorApalutamideIntervention entry›As of now · Rule based · ComparatorComparatorDarolutamideIntervention entry›As of now · Rule based · ComparatorComparatorDegarelixIntervention entry›As of now · Rule based · ComparatorComparatorEnzalutamideIntervention entry›As of now · Rule based · ComparatorComparatorGoserelinIntervention entry›As of now · Rule based · ComparatorComparatorHistrelinIntervention entry›As of now · Rule based · ComparatorComparatorLeuprolideIntervention entry›As of now · Rule based · ComparatorComparatorPrednisoneIntervention entry›As of now · Rule based · ComparatorComparatorRelugolixIntervention entry›As of now · Rule based · ComparatorComparatorTriptorelinIntervention entry›As of now · Rule based · ComparatorComparator

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Prostatic Neoplasms

From the registry record1 judgment on this link
Main condition (R9), from the registry to what was judged
RegistryProstatic Neoplasms, as filedthe registry files the study under it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
As of nowProstatic NeoplasmsRule based · main-condition ruleMain conditionCurrent
As of nowAbirateroneRule based · role ruleComparatorCurrent
As of nowApalutamideRule based · role ruleComparatorCurrent
As of nowDarolutamideRule based · role ruleComparatorCurrent
As of nowDegarelixRule based · role ruleComparatorCurrent
As of nowEnzalutamideRule based · role ruleComparatorCurrent
As of nowGoserelinRule based · role ruleComparatorCurrent
As of nowHistrelinRule based · role ruleComparatorCurrent
As of nowLeuprolideRule based · role ruleComparatorCurrent
As of nowPrednisoneRule based · role ruleComparatorCurrent
As of nowRelugolixRule based · role ruleComparatorCurrent
As of nowTriptorelinRule based · role ruleComparatorCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.